Best Information Technology Companies To Invest In 2014

If you are a faithful Netflix user, you may have noticed on Jan. 1 that some movies and television shows were no longer listed as streaming options.

Among the prominent titles that disappeared were Titanic, Flashdance, Top Gun, and Braveheart.

Netflix spokeswoman Jenny McCabe says there is no glitch in the system. Every month, as the licenses of movies and television shows expire, they are replaced by new content.

“Titles come and go … it’s just part of life,” McCabe told USA TODAY Network. “We usually re-license movies and television shows that people are regularly watching, and we choose to not re-license those that people are not watching.”

The good news for Netflix users is a number of movies and television shows have been added as streaming options.

Below is a list of many of the titles added since Jan. 1. Happy streaming!

Best Infor mation Technology Companies To Invest In 2014: First Advantage Bancorp(FABK)

First Advantage Bancorp operates as the holding company for First Federal Savings Bank that provides various financial services to individuals and businesses in Tennessee. The company offers various deposit products comprising non-interest-bearing demand deposits, such as checking accounts; interest-bearing demand accounts, including NOW and money market accounts; regular savings accounts; and certificates of deposit. Its loan portfolio include real estate mortgage loans, including one-to-four family residential loans and nonresidential real estate loans; construction loans for one-to-four family homes, commercial, multi-family, and other nonresidential purposes; land loans for developing vacant land; consumer loans consisting primarily of home equity loans; and commercial business loans secured by equipment, inventory, or accounts receivable to small businesses. As of June 10, 2010, the company operated five full-service offices in Montgomery County. First Advantage Banco rp was founded in 1953 and is headquartered in Clarksville, Tennessee.

Advisors’ Opinion:

  • [By Tim Melvin]

    PL Capital has not filed any 13Ds in a couple of months, but earlier this year it disclosed a 5.99% position in shares of First Advantage Bancorp (FABK). The Clarksville, Tenn.-based bank has seven branches and trades at about 75% of book value. PL Capital also filed a 13D announcing 8% ownership of Mutual First Financial (MFSF) over the summer. The bank has 31 branches and is based in Muncie, Ind. — an area that has seen substantial consolidation in the past few years.

Best Information Technology Companies To Invest In 2014: Discount Dental Materials Inc (DDOO)

Discount Dental Materials, Inc. (DDM), incorporated on December 18, 2007, is a development-stage company. The Company focuses on selling disposable dental supply products at discount prices over the Internet. As of November 30, 2011, the Company had not generated any revenues.

The Company focuses on selling a limited number of products including burs (modern dental drills that can rotate at up to 800,000 revolutions per minute (rpm) and generally use hard metal rotary files). Dental burs come in a variety of shapes designed for specific applications. They are often made of steel with a tungsten carbide coating or of tungsten carbide entirely. The bur may also have a diamond coating), bearings, turbines and sterilization pouches. The Company uses a facility in Burbank, California to store and ship products.

The Company competes with Henry Schein and Patterson Dental.

Advisors’ Opinion:

  • [By CRWE]

    Today, DDOO remains (0.00%) +0.000 at $1.05 thus far (ref. google finance Delayed:  3:42PM EDT July 1, 2013).

    Cerebain Biotech Corp. a subsidiary of Discount Dental Materials, Inc. , previously reported that medical device product development company, Sonos Models, Inc. (“Sonos”), is set to complete the first prototypes of its medical device solution during the company’s first fiscal quarter, which begins July 1, 2013.

    Cerebain’s President, Eric Clemons, stated, “We are excited with the imminent completion of the first set of prototypes of our Medical Device Product for the treatment of Alzheimer’s Disease. Years of hard work and research will culminate with the introduction of these prototypes which will utilize the Omentum for the treatment of patients with this debilitating disease. With these prototypes, we are introducing a leading edge approach to the treatment of Alzheimer’s Disease.”

  • [By CRWE]

    Last Friday, DDOO previously surged (+5.00%) up +0.05 at $1.05 with 10,200 shares in play at the close (ref. google finance June 28, 2013 – Close).

    Bond Laboratories, Inc. previously reported NDS launched two exciting new products at the annual GNC® Global Franchise Convention.

    Cerebain Biotech Corp. a subsidiary of Discount Dental Materials, Inc. previously reported the appointment of Dr. Surinder Saini as Chairman of its Scientific Advisory Board. The advisory board provides key clinical insight into the company’s efforts to develop and commercialize a novel approach to the treatment for patients suffering from Alzheimer’s disease. Dr. Saini is the lead scientist behind the development of the world’s first medical device specifically designed for the treatment of Alzheimer’s disease utilizing the Omentum

  • [By CRWE]

    Today, DDOO remains (0.00%) +0.000 at $1.00 thus far (ref. google finance Delayed: 10:12AM EDT June 25, 2013).

    Bond Laboratories, Inc. previously reported NDS launched two exciting new products at the annual GNC® Global Franchise Convention.

    Cerebain Biotech Corp. a subsidiary of Discount Dental Materials, Inc. previously reported the appointment of Dr. Surinder Saini as Chairman of its Scientific Advisory Board. The advisory board provides key clinical insight into the company’s efforts to develop and commercialize a novel approach to the treatment for patients suffering from Alzheimer’s disease. Dr. Saini is the lead scientist behind the development of the world’s first medical device specifically designed for the treatment of Alzheimer’s disease utilizing the Omentum

Best Information Technology Companies To Invest In 2014: Guggenheim S&P 500 Pure Growth ETF (RPG)

Rydex S&P 500 Pure Growth ETF (the Fund) seeks to replicate as closely as possible the performance of the S&P 500/Citigroup Pure Growth Index (the Index). The S Index is narrow in focus, containing only those S&P 500 companies with strong growth characteristics as selected by Standard & Poor’s. The Index contains approximately one-third of the equities of the S&P 500 Index.

The Fund uses a passive management strategy to track the performance of the Index. The Fund invests in substantially all of the securities in the Index in approximately the same proportions as in the Index. The Fund’s investment advisor is Rydex Investments.

Advisors’ Opinion:

  • [By John Udovich]

    Yesterday, small cap geothermal stock U.S. Geothermal Inc (NYSEMKT: HTM) produced a geyser of a return when it surged 26.79%, meaning its worth taking a closer look at the stock verses the performance of other geothermal stocks like small cap Ormat Technologies, Inc (NYSE: ORA) and mid cap Calpine Corporation (NYSE: CPN). First of all, I should mention there are some other geothermal stocks out there like Alterra Power Corp (CVE: AXY) and Ram Power Corp (TSE: RPG) who have their primary listing on Canadian exchanges with secondary ones on the OTC – meaning they may not be a good deal for American investors or easy to invest in. Second, U.S. Geothermal Inc itself is a good geothermal proxy as its focused on developing, owning, and operating clean, sustainable electric power from geothermal energy resources and its operating geothermal power projects at Neal Hot Springs, Oregon; San Emidio, Nevada; and Raft River, Idaho plus El Ceibillo, an advanced stage, geothermal p rospect located within a 24,710 acre energy rights concession area near Guatemala City, the largest city in Central America.

Best Information Technology Companies To Invest In 2014: Thales SA (HO)

Thales SA is a France-based provider of integrated solutions and equipment of security systems primarily to the aerospace and defense markets. The Company operates in numerous countries through its divisions, including Aerospace, specialized in onboard equipment, electronics and systems for the civil and military markets; Space, offering solutions combining space and terrestrial technologies; Defence, which designs and delivers systems for all four environments: air, land, sea and space; Security, which offer the emergence of new types of threats from terrorism and organized crime to drug trafficking, mass immigration and cyber attacks; and Transportation, which offers a range of railways signaling solutions and integrated transportation systems, to ensure safe and secure transportation of operators, freight and passengers. In November 2013, it acquired XPI Simulation Ltd. In February 2014, it created a new business line called Critical Information Systems and Cybersecurity. Advisors’ Opinion:

  • [By USATODAY 8 a.m. EST February 15]

    Alex Pettyfer about to take the wheel of the Maserati Gran Turismo for a joyride with co-star Dayo Okeniyi.(Photo: HO)

    Pettyfer and Okeniyi’s character end up joyriding in the car along with Gabriella Wilde, who plays the rich girl falling in love with Pettyfer.

Best Information Technology Companies To Invest In 2014: Worlds Inc (WDDD.OB)

Worlds Inc., (Worlds.com), incorporated on April 26, 1994, was a three-dimensional (3D) entertainment portal, which leveraged its technology, which the Company retained through its portfolio, to offer visitors a network of virtual, multi-user environments which the Company calls worlds. On May 16, 2011, the Company transferred, through a spin-off to its wholly owned subsidiary, Worlds Online Inc., the majority of its operations and related operational assets. The Company designs and develops software, content and related technology for the creation of interactive, three-dimensional (3D) Internet Web sites. The Company used its technology to produce three-dimensional portals and Web sites. The Company’s core technology includes WorldsShaper, WorldsServer, WorldsBrowser, WorldsPlayer and Worlds Gamma Libraries.

WorldsShaper is the visual authoring component of the Company’s platform. It allows for quick assembly of pieces to create multi-user, shared state, virt ual worlds. The WorldsShaper is an advanced compositing 3D building tool that integrates pre-existing or custom content, such as 3D models, textures or images created in Adobe’s Photoshop, or midi or wave sound files, with architectural geometry and interactive behaviors and actions written in Java. WorldsServer is the scalable software that the Company uses to control and operates its on-line virtual communities. WorldsServer manages the registration and authentication of users, the locations of users within the 3D environment, the physical structure of the 3D environment, all information regarding objects that are shared by the participants and any of the interactions between the users such as text chat. This platform also integrates an HTTP server for the delivery of other content such as audio and video streaming and secure e-commerce applications.

WorldsBrowser is used to access the 3D environments. The browser is optimized for speed, delivering relatively fast frame rates per second in textured virtual 3D worlds. T! he WorldsPlayer allows users to view and experience the Company’s multi-user, interactive technology. Any world created with the WorldsShaper will be viewable and navigable with the WorldsPlayer. The Worlds Gamma Libraries are consists of sample worlds, textures, models, avatars, actions, sensors, sounds, motion sequences, and other behaviors.

Advisors’ Opinion:

  • [By Markman Advisors]

    Public companies leveraging their patent portfolios, (aka "patent plays"), are getting the market’s attention. Companies such as Vringo (VRNG), ParkerVision (PRKR), MGT Capital (MGT), Worlds Inc. (WDDD.OB) and others have presented trading opportunities due to their volatility while retaining the chance for a big payoff to those investors who stay the course. Yet there exist viable patent plays that are still undiscovered. Some of these so called "plays," which are not getting enough attention, are actually real companies making and selling real products or services in contrast to pure patent monetization companies. Some known examples are Single Touch Interactive (SITO.OB) and Blue Calypso (BCYP.OB). This article is focused on another one of these patent plays, On Track Innovations Ltd. (OTIV).

Best Information Technology Companies To Invest In 2014: ONEOK Partners L.P.(OKS)

ONEOK Partners, L.P. engages in the gathering, processing, storage, and transportation of natural gas in the United States. The company?s Natural Gas Gathering and Processing segment gathers and processes natural gas produced from crude oil and natural gas wells located in the Mid-Continent region; and gathers natural gas in the Williston Basin, which spans portions of Montana and North Dakota, and the Powder River Basin of Wyoming. Its Natural Gas Pipelines segment primarily owns and operates regulated natural gas transmission pipelines, natural gas storage facilities, and natural gas gathering systems for non-processed gas. It also provides interstate natural gas transportation and storage services. This segment?s interstate natural gas pipeline assets transport natural gas through FERC-regulated interstate natural gas pipelines in North Dakota, Minnesota, Wisconsin, Illinois, Indiana, Kentucky, Tennessee, Oklahoma, Texas, and New Mexico. In addition, it transports intra state natural gas through its assets in Oklahoma; and owns underground natural gas storage facilities in Oklahoma, Kansas, and Texas. Its Natural Gas Liquids segment gathers, fractionates, and treats natural gas liquids (NGLs), as well as stores NGL products primarily in Oklahoma, Kansas, and Texas. This segment owns FERC-regulated natural gas liquids gathering and distribution pipelines in Oklahoma, Kansas, Texas, Wyoming, and Colorado; terminal and storage facilities in Missouri, Nebraska, Iowa, and Illinois; and FERC-regulated natural gas liquids distribution and refined petroleum products pipelines in Kansas, Missouri, Nebraska, Iowa, Illinois, and Indiana that connect its Mid-Continent assets with Midwest markets, including Chicago, Illinois. ONEOK Partners GP serves as the general partner of the company. The company was formerly known as Northern Border Partners, L.P. and changed its name to ONEOK Partners, L.P. in May 2006. The company was founded in 1993 and is base d in Tulsa, Oklahoma.

Advisors’ Opinion:

  • [By Paul Ausick]

    Large MLPs with geographically diversified operations will fare better because they can shift assets around and make sure that all their distribution-paying subsidiaries meet the payroll, so to speak. Here are the seven largest MLPs by market cap:

    Enterprise Product Partners LP (NYSE: EPD) – $61.23 billion Kinder Morgan Energy Partners LP (NYSE: KMP) – $35.13 billion Williams Partners LP (NYSE: WPZ) – $21.95 billion Plains All American Pipeline LP (NYSE: PAA) – $19.3 billion Energy Transfer Partners LP (NYSE: ETP) – $17.78 billion Magellan Midstream Partners LP (NYSE: MMP) – $15.52 billion Oneok Partners LP (NYSE: OKS) – $12.95 billion

    Size is not the only thing that matters, but size can help overcome some of the cash flow issues these MLPs face. The differentiating factor is a company’s distribution coverage ratio which is the cash the MLP has to distribute to its limited partners divided by its maintenance capex and interest on the company’s debt. Anything number larger than 1 is solid.

  • [By Lauren Pollock]

    Oneok Partners LP(OKS) issued guidance for 2014 that surpasses its estimate for the current year, citing growth in natural-gas volumes.

    QEP Resources Inc.(QEP) plans to separate its midstream business, QEP Field Services Co., into a separate entity, including its interest in QEP Midstream Partners LP(QEPM).

  • [By David Dittman]

    Answer: ONEOK is running wild in anticipation of its completion of transactions that will make it essentially a general partner, with interests in ONEOK Partners LP (NYSE: OKS) and the soon-to-be-spun-out ONE Gas Inc (NYSE: OGS). ONEOK already has an admirable record of dividend growth, and these moves will drive acceleration in 2014 payout growth.

Best Information Technology Companies To Invest In 2014: Navidea Biopharmaceuticals Inc (NAVB)

Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, incorporated in 1983, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents. As of December 31, 2011, the Company’s radiopharmaceutical development programs included Lymphoseek (Lymphoseek, Kit for the Preparation of Technetium Tc99m for Injection), a radiopharmaceutical agent for lymph node mapping; AZD4694, an imaging agent, and RIGScan, a tumor antigen-specific targeting agent. In January 2012, the Company executed an option agreement with Alseres Pharmaceuticals, Inc. (Alseres) to license [123I]-E-IACFT Injection, also called Altropane, an Iodine-123 radiolabeled imaging agent, being developed as an aid in the diagnosis of Parkinson’s disease, movement disorders and dementia. In August 2011, the Company sold its gamma detection device line of business (the GDS Business) to Devicor Medical Products, Inc.

Lymphoseek

< /p>

Navidea’s pipeline includes clinical-stage radiopharmaceutical agents used to identify the presence and status of disease. Lymphoseek (Kit for the Preparation of Technetium Tc99m for Injection) is a lymph node targeting agent intended for use in intraoperative lymphatic mapping (ILM) procedures and lymphoscintigraphy employed in the overall diagnostic assessment of certain solid tumor cancers. The lymph system is a component of the body’s immune system. The key components of the lymph system are lymph nodes-small anatomic structures that contain disease-fighting lymphocytes, filter lymph of bacteria and cancer cells, and signal infection in response to heightened levels of pathogens. In Navidea’s Phase III clinical studies of Lymphoseek, it detected over 99% of positive nodes identified by vital blue dye (VBD). As of December 31, 2011, Navidea, in co-operation with UC, San Diego affiliate (UCSD), completed or initiated five Phase I clinical trials, one multi-cent er Phase II trial and three multi-center Phase II trials inv! olving Lymphoseek. Two Phase III studies were completed in subjects with breast cancer and melanoma. During the year ended December 31, 2011, data from NEO3-09 were released, which indicated that all primary and secondary endpoints for the study were met. As of December 31, 2011, third Phase III clinical trial for Lymphoseek in subjects with head and neck squamous cell carcinoma (NEO3-06) was in progress.

AZD4694

AZD4694 is a Fluorine-18 labeled precision radiopharmaceutical candidate for use in the imaging and evaluation of patients with signs or symptoms of cognitive impairment such as Alzheimer’s disease (AD). It binds to beta-amyloid deposits in the brain that can then be imaged in positron emission tomography (PET) scans. Amyloid plaque pathology is a required feature of AD and the presence of amyloid pathology is a supportive feature for diagnosis of probable AD. Patients who are negative for amyloid pathology do not have AD. AZD4694 has been studied in several clinical trials. Clinical studies through Phase IIa have included more than 80 patients to date, both suspected AD patients and healthy volunteers. No significant adverse events have been observed. Results suggest that AZD4694 has the ability to image patients quickly and safely with high sensitivity.

RadioImmunoGuided Surgery

As of December 31, 2011, RIGScan had been studied in a number of clinical trials, including Phase III studies. Navidea has conducted two Phase III studies, NEO2-13 and NEO2-14, of RIGScan in patients with primary and metastatic colorectal cancer, respectively. Both studies were multi-institutional involving cancer treatment institutions in the United States, Israel, and the European Union.

The Company competes with Pharmalucence, Eli Lilly, Bayer Schering, General Electric and GE Healthcare.

Advisors’ Opinion:

  • [By Lauren Pollock]

    Navidea Biopharmaceuticals Inc.(NAVB) said the U.S. Food and Drug Administration has granted a priority review for an expanded use of its Lymphoseek drug for some patients with head and neck cancer. Shares dropped 5.4% to $1.97 premarket.

  • [By Lauren Pollock]

    Among the companies with shares expected to actively trade in Tuesday’s session are Toll Brothers Inc.(TOL) and Navidea Biopharmaceuticals Inc.(NAVB)

  • [By Sean Williams]

    Diagnostics can also play an important role in early and late-stage breast cancer diagnoses. Navidea Biopharmaceuticals (NYSEMKT: NAVB  ) had Lymphoseek, its external lymph-node imaging and intra-operative lymphatic mapping diagnostic device, approved by the Food and Drug Administration earlier this year to help doctors stage cancer. Discovering whether breast cancer has invaded adjacent lymph nodes has never been easier or safer thanks to Lymphoseek, and it can dramatically aid physicians in determining the best course of action for breast cancer patients.

  • [By Keith Speights]

    3. Navidea Biopharmaceuticals (NYSEMKT: NAVB  )
    Some investors were likely befuddled by Navidea’s stock action earlier this year. The company received FDA approval in March for Lymphoseek, its radiopharmaceutical agent used for imaging lymph nodes in patients with breast cancer or melanoma. That was great news, but shares dropped quickly and still haven’t returned to previous levels.

Best Information Technology Companies To Invest In 2014: Solitron Devices Inc (SODI)

Solitron Devices, Inc., incorporated on March 12, 1987, designs, develops, manufactures and markets solid-state semiconductor components and related devices primarily for the military and aerospace markets. The Company manufactures a variety of bipolar and metal oxide semiconductor (MOS) power transistors, power and controls hybrids, junction and power MOS field effect transistors (Power MOSFETS), field effect transistors and other related products. It’s products are custom made pursuant to contracts with customers whose end products are sold to the United States government. The Company’s semiconductor products can be classified as active electronic components. The Company’s active electronic components include bipolar transistors and MOS transistors.

The Company’s semiconductor products are used as components of military, commercial, and aerospace electronic equipment, such as ground and airborne radar systems, power distribution systems, missiles, miss ile control systems, and spacecraft. Its products have been used on the space shuttle and on the spacecraft sent to the moon, to Jupiter (on Galileo) and, to Mars (on Global Surveyor and Mars Sojourner).

Power Transistors

The Company manufactures a variety of power bipolar transistors for applications requiring currents in the range of 0.1 ampere to 300 ampere or voltages in the range of 30 volts to 1000 volts. It also manufactures power diodes under the same military specification. In addition, it manufactures power N-Channel and P-Channel MOSFET transistors and is expanding that line in accordance with customers’ requirements.

Hybrids

The Company manufactures thick film hybrids, which generally contain discrete semiconductor chips, integrated circuits, chip capacitors and thick film or thin film resistors. The hybrids are of the high-power type and are custom manufactured for military and aerospace systems. Some of the Company’s hybrids include high power voltage regulators, p! ower amplifiers, power drivers, boosters and controllers. The Company manufactures both standard and custom hybrids.

Voltage Regulators

Voltage regulators provide the power required to activate electronic components such as the integrated circuits. These circuits are found in all electronic devices from radar and missile systems to smart phones.

Field Effect Transistors

The Company manufactures about 30 different types of junction and MOS field effect transistor chips. They are used to produce over 350 different field effect transistor types. The Company’s field effect transistors conform to standard Joint Electronic Device Engineering Council designated transistors, commonly referred to as standard 2N number types. It manufactures both standard and custom field effect transistors.

The Competes with IXYS Corporation, Motorola Inc., International Rectifier, Microsemi Corporation, M.S. Kennedy Corporation, Nat el Engineering Company and Sensitron Semiconductor.

Advisors’ Opinion:

  • [By Geoff Gannon] strong>OPT-Sciences (OPST)

    Micropac

    Micropac is 76% owned by Heinz-Werner Hempel. He’s a German businessman. You can see the German company he founded here. He’s had control of Micropac for a long-time. I don’t have an exact number in front of me. But I would guess it’s been something like 25 years.

    ADDvantage

    ADDvantage Technologies is controlled by the Chymiak brothers. See the company’s April 4 press release explaining their decision to turn over the CEO position to an outsider. Regardless, the Chymiaks still control 47% of the company. Ken Chymiak is now chairman. And David Chymiak is still a director and now the company’s chief technology officer. Clearly, it’s still their company.

    By the way, the name ADDvantage Technologies has nothing to do with the Chymiaks. Today’s AEY really traces its roots to a private company called Tulsat. The Chymiak brothers acquired that company about 27 years ago. So, effectively, when you buy shares of AEY you are buying into a 27-year-old family-controlled company.

    That’s pretty typical in the world of net-nets.

    Solitron

    Solitron Devices is 29% owned by Shevach Saraf. He has been the CEO for 20 years. The post-bankruptcy Solitron has never known another CEO. Before the bankruptcy, Solitron was a much bigger, much different company. So even though we are not talking about the founder here – and even though 70% of the company’s shares are not held by the CEO – we’re still talking about a company where one person has a lot of control. Solitron only has three directors. Saraf is the chairman, CEO, president, CFO and treasurer. Neither of the other two directors joined the board within the last 15 years. So, we aren’t talking about a lot of tumult at the top.

    In fact, profitable net-nets seem to be especially common candidates for abandoning the responsibilities of a public company without actually getting taken private.

    OPT -Sciences

    This

  • [By Geoff Gannon]

    Solitron (SODI) sells at 74% of NCAV, has decent z- and f-scores, a FCF margin of 5.3% and an ROA of 12%.

    Micropac (MPAD) sells at 83% of NCAV, has similar (slightly better) z- and f-scores, a FCF margin of 6%, but has ROA of 28%.

    ADDvantage (AEY) sells at 95% of NCAV, has similar (in the ballpark) scores and FCF and ROA of 23%.

  • [By Geoff Gannon] on the amount of stock you can buy and the position size you like. For me, I try not to start buying a stock that I think will never make up 10% of my portfolio. If you don’t mind having 5% positions in your portfolio, your portfolio can obviously be twice as big as mine and you can still consider buying the same small stocks I do. In terms of specific stocks, it depends on the amount of float and the volume the stock trades in an average month. We are really getting into specifics here. And I may be boring people. But if you’d like to hear more about the minutiae of how you actually buy and sell tiny stocks like these, let me know, and I’ll do an article on the subject.

    By the way, there is a hard and fast rule of thumb that it usually makes no sense to invest in a company with a market cap that is smaller than your portfolio. This is true for both fund and individual investors. Funds break it all the time. But, frankly, it is probably a waste of an analyst/fund manager’s time to even analyze such tiny positions relative to the size of the whole portfolio. Since even when we are discussing very small stocks we are still talking about millions and millions of dollars in market cap, this is hardly a concern for most individuals.

    So, for individual investors, actual inability to acquire enough shares of a company to meaningful influence their portfolio is rarely the problem. If you bid for a stock month after month — you’ll get your shares.

    The concern for individual investors is not whether buying enough shares is possible. The concern is how quickly and easily you can buy and sell. This is what we call “liquidity.”

    Instead of thinking about stocks as liquid or illiquid, you should think in terms of your portfolio and your liquidity needs. It doesn’t make much sense to use what I’ll call an “objective” (as in stock-oriented) approach to liquidity rather than a “subjective” (as in investor-oriented) approa ch to liquidity.

    <